Relapse Protection Following Early Cytomegalovirus Reactivation after Hematopoietic Stem Cell Transplantation Is Limited to HLA-C Killer Cell Immunoglobulin-Like Receptor Ligand Homozygous Recipients
Alexander Nikoloudis(Johannes Kepler University of Linz), Johannes Clausen(Johannes Kepler University of Linz), Sigrid Machherndl‐Spandl(Krankenhaus der Elisabethinen), Andreas Petzer(Ordensklinikum Linz Barmherzige Schwestern), Emine Kaynak(Krankenhaus der Elisabethinen), Dominik Wolf(Universität Innsbruck), Veronika Buxhofer‐Ausch(Johannes Kepler University of Linz), David Nachbaur(Innsbruck Medical University), Robert Milanov(Krankenhaus der Elisabethinen), Michaela Binder(Durham University), Irene Straßl(Krankenhaus der Elisabethinen), Helga Wagner(Johannes Kepler University of Linz), Dagmar Wipplinger(Krankenhaus der Elisabethinen), Ansgar Weltermann, Petra Hasengruber(Krankenhaus der Elisabethinen), Olga Stiefel(Krankenhaus der Elisabethinen)
Cited by 7
Related Papers
High Plasma Levels of Factor VIII and the Risk of Recurrent Venous Thromboembolism
|New England Journal of Medicine|2000|764
Survival and Disease Progression in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International Study
|Journal of Clinical Oncology|2011|540
Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial
|Nature Medicine|2021|523